Rapid Micro Biosystems (RPID) Set to Announce Earnings on Friday

Rapid Micro Biosystems (NASDAQ:RPID) is set to issue its quarterly earnings data before the market opens on Friday, November 1st. Analysts expect the company to announce earnings of ($0.26) per share for the quarter. Rapid Micro Biosystems has set its FY 2024 guidance at EPS.Parties that wish to listen to the company’s conference call can do so using this link.

Rapid Micro Biosystems (NASDAQ:RPID) last released its quarterly earnings results on Friday, August 2nd. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.28) by ($0.01). Rapid Micro Biosystems had a negative net margin of 204.22% and a negative return on equity of 45.23%. The company had revenue of $6.62 million during the quarter, compared to analyst estimates of $6.02 million. During the same quarter last year, the company earned ($0.33) EPS. On average, analysts expect Rapid Micro Biosystems to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Rapid Micro Biosystems Stock Up 2.8 %

Shares of NASDAQ:RPID opened at $1.11 on Thursday. The firm has a market cap of $47.63 million, a price-to-earnings ratio of -0.95 and a beta of 1.13. Rapid Micro Biosystems has a 12 month low of $0.58 and a 12 month high of $1.18. The company’s fifty day simple moving average is $0.88 and its 200 day simple moving average is $0.82.

Insider Activity

In other news, Director Kirk Malloy acquired 50,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 8th. The stock was acquired at an average cost of $0.91 per share, for a total transaction of $45,500.00. Following the completion of the acquisition, the director now owns 64,300 shares in the company, valued at $58,513. This represents a 300.00 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other Rapid Micro Biosystems news, Director Richard S. Kollender purchased 65,000 shares of the business’s stock in a transaction on Tuesday, August 6th. The shares were purchased at an average cost of $0.77 per share, with a total value of $50,050.00. Following the transaction, the director now directly owns 96,718 shares of the company’s stock, valued at $74,472.86. This represents a 200.00 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Kirk Malloy acquired 50,000 shares of the firm’s stock in a transaction dated Thursday, August 8th. The stock was bought at an average price of $0.91 per share, with a total value of $45,500.00. Following the acquisition, the director now directly owns 64,300 shares in the company, valued at $58,513. This represents a 300.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have bought a total of 175,000 shares of company stock worth $141,850 over the last three months. Corporate insiders own 30.40% of the company’s stock.

About Rapid Micro Biosystems

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.